Survival Curve Insights
The discussion centers around the Kaplan-Meier survival curve, highlighting the stark differences between the placebo and treatment groups. Notably, one individual in the placebo group survived for an impressive 44 months, prompting reflections on overall survival rates. The analysis reveals a concerningly low median survival for the GP 100 group, emphasizing the critical nature of understanding these survival metrics in treatment evaluations.In this clip
From this podcast
Huberman Lab
Journal Club with Dr. Peter Attia | Effects of Light & Dark on Mental Health & Treatments for Cancer
Related Questions